Genetic basis and therapies for vascular anomalies

A Queisser, E Seront, LM Boon, M Vikkula - Circulation research, 2021 - Am Heart Assoc
Vascular and lymphatic malformations represent a challenge for clinicians. The identification
of inherited and somatic mutations in important signaling pathways, including the PI3K …

Functional assessment of two variants of unknown significance in TEK by endothelium-specific expression in zebrafish embryos

LM Bell, A Holm, U Matysiak, W Driever… - Human molecular …, 2022 - academic.oup.com
Vascular malformations are most often caused by somatic mutations of the PI3K/mTOR and
the RAS signaling pathways, which can be identified in the affected tissue. Venous …

[HTML][HTML] Cell populations expressing stemness-associated markers in vascular anomalies

EJ Kilmister, L Hansen, PF Davis, SRR Hall… - Frontiers in surgery, 2021 - frontiersin.org
Treatment of vascular anomalies (VAs) is mostly empirical and, in many instances
unsatisfactory, as the pathogeneses of these heterogeneous conditions remain largely …

[HTML][HTML] Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations

P Brouillard, MJ Schlögel, N Homayun Sepehr… - Orphanet journal of rare …, 2021 - Springer
Background Theragnostic management, treatment according to precise pathological
molecular targets, requests to unravel patients' genotypes. We used targeted next …

[HTML][HTML] Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum

VER Parker, KM Keppler-Noreuil, L Faivre, M Luu… - Genetics in …, 2019 - Elsevier
Purpose PIK3CA-related overgrowth spectrum (PROS) encompasses a range of debilitating
conditions defined by asymmetric overgrowth caused by mosaic activating PIK3CA variants …

When, where and which PIK3CA mutations are pathogenic in congenital disorders

A Angulo-Urarte, M Graupera - Nature Cardiovascular Research, 2022 - nature.com
PIK3CA encodes the class I PI3Kα isoform and is frequently mutated in cancer. Activating
mutations in PIK3CA also cause a range of congenital disorders featuring asymmetric tissue …

Alpelisib to treat CLOVES syndrome, a member of the PIK3CA‐related overgrowth syndrome spectrum

G Garreta Fontelles, J Pardo Pastor… - British journal of …, 2022 - Wiley Online Library
CLOVES syndrome is a rare congenital overgrowth disorder caused by mutations in the
phosphatidylinositol 3‐kinase catalytic subunit alpha (PIK3CA) gene. It is part of the PIK3CA …

Trametinib as a promising therapeutic option in alleviating vascular defects in an endothelial KRAS-induced mouse model

HL Nguyen, LM Boon, M Vikkula - Human Molecular Genetics, 2023 - academic.oup.com
Somatic activating Kirsten rat sarcoma viral oncogene homologue (KRAS) mutations have
been reported in patients with arteriovenous malformations. By producing LSL-Kras (G12D); …

[HTML][HTML] Comprehensive phenotypic and genomic characterization of venous malformations

K Hirose, Y Hori, M Ozeki, D Motooka, K Hata… - Human Pathology, 2024 - Elsevier
Venous malformations (VMs) are the most common vascular malformations. TEK and
PIK3CA are the causal genes of VMs, and may be involved in the PI3K/AKT pathway …

Development of molecular therapies for venous malformations

J Kangas, M Nätynki, L Eklund - Basic & Clinical Pharmacology …, 2018 - Wiley Online Library
Vascular anomalies are localized defects of morphogenesis that can affect lymphatic and
blood vessels. They are generally called birthmarks, typically observed soon after birth and …